Stock Analysts’ New Coverage for October 14th (AGNT, APRE, COMP, DOUG, ENTG, GRMN, IDYA, JSPR, KEX, Q)

Stock Analysts’ new coverage for Wednesday, October 14th:

Citizens Jmp initiated coverage on shares of Exp World (NASDAQ:AGNT). Citizens Jmp issued a market outperform rating and a $6.00 target price on the stock.

LADENBURG THALM/SH SH started coverage on shares of Aprea Therapeutics (NASDAQ:APRE). They issued a buy rating and a $2.00 target price on the stock.

Citizens Jmp started coverage on shares of Compass (NYSE:COMP). Citizens Jmp issued a market outperform rating and a $11.00 target price on the stock.

Citizens Jmp began coverage on shares of Douglas Elliman (NYSE:DOUG). The firm issued a market perform rating on the stock.

Truist Financial Corporation started coverage on shares of Entegris (NASDAQ:ENTG). The firm issued a buy rating and a $190.00 price target on the stock.

Arete Research initiated coverage on shares of Garmin (NYSE:GRMN). The firm issued a buy rating and a $335.00 target price on the stock.

Stifel Nicolaus began coverage on shares of IDEAYA Biosciences (NASDAQ:IDYA). Stifel Nicolaus issued a buy rating and a $48.00 target price on the stock.

William Blair initiated coverage on shares of Jasper Therapeutics (NASDAQ:JSPR). William Blair issued an outperform rating on the stock.

JPMorgan Chase & Co. assumed coverage on shares of Kirby (NYSE:KEX). They issued an overweight rating and a $200.00 target price on the stock.

Truist Financial Corporation initiated coverage on shares of Qnity Electronics (NYSE:Q). They issued a buy rating and a $170.00 target price on the stock.

JPMorgan Chase & Co. began coverage on shares of Arcus Biosciences (NYSE:RCUS). The firm issued an overweight rating and a $41.00 price target on the stock.

Citizens Jmp initiated coverage on shares of Real REMAX Group (NASDAQ:REAX). The firm issued a market outperform rating and a $40.00 target price on the stock.

Cantor Fitzgerald started coverage on shares of Sol-Gel Technologies (NASDAQ:SLGL). The firm issued an overweight rating on the stock.

Canaccord Genuity Group Inc. started coverage on shares of Seaport Therapeutics (NASDAQ:SPTX). Canaccord Genuity Group Inc. issued a buy rating and a $28.00 price target on the stock.

JPMorgan Chase & Co. started coverage on shares of Standex International (NYSE:SXI). JPMorgan Chase & Co. issued a neutral rating and a $320.00 target price on the stock.

Stifel Nicolaus started coverage on shares of Americas Gold and Silver (NYSEAMERICAN:USAS). They issued a buy rating on the stock.